Apelanio, Arialyn .

HRN: 27-64-79  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2025
CEFUROXIME 500MG (TAB)
08/19/2025
08/25/2025
ORAL
500mg
BID X 7days
Sp NSVD With RMLE
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: